Pts IC | Pts ADV | Place | Nég | % | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
max | min | moy | min | max | moy | min | max | moy | min | max | moy | max | min | moy | 4 | 0 | 1.57 | 4 | 7 | 5.14 | 9 | 14 | 11 | -185 | -339 | -277 | 79.54 | 63.91 | 69.98 |
Tour | Match | Score | Plc | IC | ADV | Top | Pts | % | ic | adv | plc | nég | % | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | SRMa-PHEb | 46.0-32.0 | 9 | 4.0 | 5.0 | 932 | -226 | 75.75 | x | x | ||||||||
4 | ASSb-PHEb | 39.0-39.0 | 11 | 2.0 | 5.0 | 904 | -185 | 79.54 | x | x | ||||||||
5 | PHEb-CRQa | 50.0-28.0 | 11 | 0.0 | 4.0 | 946 | -339 | 64.16 | x | x | x | |||||||
6 | PHEb-KIHb | 41.0-37.0 | 13 | 0.0 | 5.0 | 834 | -301 | 63.91 | x | x | ||||||||
8 | PHEb-SRMa | 28.0-50.0 | 12 | 2.0 | 7.0 | 1026 | -319 | 68.91 | x | |||||||||
9 | PHEb-ASSb | 39.0-39.0 | 14 | 0.0 | 6.0 | 839 | -301 | 64.12 | x | x | ||||||||
10 | CRQa-PHEb | 34.0-44.0 | 10 | 3.0 | 4.0 | 969 | -265 | 72.65 | x |